{"id":2766,"date":"2008-09-24T00:01:41","date_gmt":"2008-09-23T23:01:41","guid":{"rendered":"http:\/\/www.ethicalquote.com\/index.php\/2008\/09\/24\/eli-lilly-to-disclose-financial-ties-to-doctors-a-drug-industry-first\/"},"modified":"2008-09-24T15:09:57","modified_gmt":"2008-09-24T14:09:57","slug":"eli-lilly-to-disclose-financial-ties-to-doctors-a-drug-industry-first","status":"publish","type":"post","link":"https:\/\/www.covalence.ch\/index.php\/2008\/09\/24\/eli-lilly-to-disclose-financial-ties-to-doctors-a-drug-industry-first\/","title":{"rendered":"Eli Lilly to disclose financial ties to doctors, a drug industry first"},"content":{"rendered":"<p><a href=\"http:\/\/thehill.com\/business--lobby\/eli-lilly-to-disclose-financial-ties-to-doctors-a-drug-industry-first-2008-09-23.html\" target=\"_blank\" title=\"080924_lilly.jpg\"><img decoding=\"async\" src=\"http:\/\/www.ethicalquote.com\/newTemplate\/wp-content\/uploads\/2008\/09\/080924_lilly.jpg\" title=\"080924_lilly.jpg\" alt=\"080924_lilly.jpg\" align=\"right\" \/><\/a>The drug maker Eli Lilly &amp; Co. plans to create a public database listing the names of physicians it pays for speaking engagements and consulting services, the company will announce Wednesday.  The new policy puts Lilly at the forefront of the drug industry as the firm seeks to cement its reputation as a leader in the pharmaceutical sector\u2019s halting progress toward greater transparency. Image source: adonisconstruction.co.uk. &gt; <a href=\"http:\/\/thehill.com\/business--lobby\/eli-lilly-to-disclose-financial-ties-to-doctors-a-drug-industry-first-2008-09-23.html\" target=\"_blank\">Continue<\/a>.<\/p>\n<p>News selected by Covalence <span class=\"LinkBlueTransMedium\">| Country: <\/span>Global <span class=\"LinkBlueTransMedium\">| Company: <\/span><a href=\"http:\/\/www.ethicalquote.com\/newTemplate\/index.php\/ethicalquote\/?value=6\"><span name=\"intelliTxt\" id=\"intelliTXT\"><\/span><\/a><a href=\"http:\/\/www.ethicalquote.com\/newTemplate\/index.php\/ethicalquote\/?value=5\"><span class=\"LinkBlueTransMedium\"><\/span><\/a><a href=\"http:\/\/www.ethicalquote.com\/newTemplate\/index.php\/ethicalquote\/?value=8\">Eli Lilly<\/a><span lang=\"EN-GB\"> <\/span><span class=\"LinkBluePgtMedium\"><span style=\"font-size: 9pt; font-family: Arial\"><\/span><\/span><span class=\"LinkBlueTransMedium\">| <\/span>Source: <a href=\"http:\/\/thehill.com\/business--lobby\/eli-lilly-to-disclose-financial-ties-to-doctors-a-drug-industry-first-2008-09-23.html\" target=\"_blank\">The Hill<br \/>\n<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The drug maker Eli Lilly &amp; Co. plans to create a public database listing the names of physicians it pays for speaking engagements and consulting services, the company will announce Wednesday. The new policy puts Lilly at the forefront of the drug industry as the firm seeks to cement its reputation as a leader in&hellip;<\/p>\n","protected":false},"author":665,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"wds_primary_category":0,"wds_primary_post_series":0,"footnotes":""},"categories":[1],"tags":[106],"post_series":[],"class_list":["post-2766","post","type-post","status-publish","format-standard","hentry","category-news","tag-eli-lilly","entry","no-media"],"_links":{"self":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/2766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/users\/665"}],"replies":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/comments?post=2766"}],"version-history":[{"count":0,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/2766\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/media?parent=2766"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/categories?post=2766"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/tags?post=2766"},{"taxonomy":"post_series","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/post_series?post=2766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}